# A Study of RO5028442 in Adult Male High-Functioning Autistic Patients

> **NCT01474278** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 19 (actual)

## Conditions studied

- Autistic Disorder

## Interventions

- **DRUG:** Placebo
- **DRUG:** RO5028442

## Key facts

- **NCT ID:** NCT01474278
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01474278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01474278, "A Study of RO5028442 in Adult Male High-Functioning Autistic Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01474278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*